The University of Iowa

Publications

Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol

Giovanni Berardi, Laura Frey-Law, Kathleen A Sluka, Emine O Bayman, Christopher S Coffey, Dixie Ecklund, Carol G T Vance, Dana L Dailey, John Burns, Asokumar Buvanendran, Robert J McCarthy, Joshua Jacobs, Xiaohong Joe Zhou, Richard Wixson, Tessa Balach, Chad M Brummett, Daniel Clauw, Douglas Colquhoun, Steven E Harte, Richard E Harris, David A Williams, Andrew C Chang, Jennifer Waljee, Kathleen M Fisch, Kristen Jepsen, Louise C Laurent, Michael Olivier, Carl D Langefeld, Timothy D Howard, Oliver Fiehn, Jon M Jacobs, Panshak Dakup, Wei-Jun Qian, Adam C Swensen, Anna Lokshin, Martin Lindquist, Brian S Caffo, Ciprian Crainiceanu, Scott Zeger, Ari Kahn, Tor Wager, Margaret Taub, James Ford, Stephani P Sutherland, Laura D Wandner
Front Med (Lausanne). 2022 April 25; 9

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

Griguer CE, Oliva CR, Coffey CS, Cudkowicz ME, Conwit RA, Gudjonsdottir AL, Ecklund DJ, Fedler JK, Neill-Hudson TM, Nabors LB, Benge M, Hackney JR, Chase M, Leonard TP, Patel T, Colman H, de la Fuente M, Chaudhary R, Marder K, Kreisl T, Mohile N, Chheda MG, McNeill K, Kumthekar P, Dogan A, Drappatz J, Puduvalli V, Kowalska A, Graber J, Gerstner E, Clark S, Salacz M, Markert J.
Neurooncology Advances. 2021 December 24; 4 (1) doi: 10.1093/noajnl/vdab1.
PubMed: 

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study

Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team.
Neurology. 2021 December 2; (DOI: https://doi.org/10.1)

Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Tria

Scott W. Powers, PhD; Christopher S. Coffey, PhD; Leigh A. Chamberlin, RD, MEd; Dixie J. Ecklund, RN, MSN; Elizabeth A. Klingner, MS; Jon W. Yankey, MS; James L. Peugh, PhD; Leslie L. Korbee, BS; Kerry Simmons, BS; Stephanie M. Sullivan, BS; Marielle A. Kabbouche, MD; Joanne Kacperski, MD; Linda L. Porter, PhD; Brooke L. Reidy, PhD; Andrew D. Hershey, MD, PhD
JAMA Network Open. 2021 July 12; 4 (7)
PubMed: